CB Health Ventures

CB Health Ventures operates as the dedicated healthcare venture investment vehicle within a larger family of operating companies that have long-standing interests in life sciences and health services. The broader CB family provides shared infrastructure, industry networks, and permanent capital. This structure allows the venture arm to function with a patient-capital mandate, unconstrained by traditional fund-life timelines.

The firm focuses on seed and Series A rounds, with selective follow-on participation through Series B. Its investment activity concentrates on companies that have progressed beyond concept validation and require capital for clinical studies, regulatory submissions, or initial commercial scaling. Specific check-size ranges are not publicly disclosed.

Yes. The firm actively participates in syndicated rounds with other healthcare-specialist venture funds, leveraging its sector expertise and operating-company network as differentiating value-add. Its co-investors are typically drawn from the specialized healthcare venture community rather than generalist technology funds.

Based on its stated mandate, the firm avoids non-healthcare sectors entirely. Within healthcare, there is no public evidence of investment in hospital real estate, revenue-cycle management outsourcing, or mature pharmaceutical distribution — areas that fall outside its innovation-stage digital health, medical device, and biotech focus.

The firm sources primarily through the existing relationship networks of its principals and the broader CB operating companies, rather than through public inbound channels. Its healthcare-executive network — spanning hospital systems, pharmaceutical companies, and payors — provides proprietary visibility into early-stage companies emerging from clinical and academic settings.